← Leaderboards
Patrik Brundin
Van Andel Research Institute
$3,355,919
Attributed
$5,195,338
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2014–20$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$5,195,338 · 8
By mechanism
R01$2,696,445 · 2
R21$2,473,893 · 4
R13$25,000 · 2
Top collaborators
- Daniel W Wesson4 shared
- Jeffrey H Kordower2 shared
- Merritt Kearny Taylor2 shared
Most similar at Van Andel Research Institute
Same institution · by research overlap
- Darren John Moore$10,901,167
- Merritt Kearny Taylor$253,988
- Thomas Goralski$26,651
Others in their field
Top investigators on “Parkinson Disease”
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$92,426,001
- David M Anderson · University Of Washington$40,483,703
- Daniel M Corcos · Northwestern University$37,632,589
- Joel Synes Perlmutter · Washington University$37,192,743
- Jerrold L Vitek · University Of Minnesota$35,135,315
- Joseph B Martin · Harvard University (Medical School)$26,652,023
Research focus
Parkinson DiseaseMissionUnited States National Institutes Of HealthAlpha SynucleinNeuronsNeurodegenerative DisordersPathologyNeuropathologyDesignPathogenesisPublic HealthDisease ProgressionInnovationBrainPathogenicityMotor DisorderNerve DegenerationAffectFunctional DisorderNeuroinflammationMorbidity - Disease RateMolecularIn VivoNational Institute Of Neurological Disorders And Stroke
Grant awards (14)
Linking Synucleinopathy and Dysfunction of Olfactory Pathways$560,384
R01 · FY2020 · DC · contact PI
Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons disease$449,748
R21 · FY2020 · NS · contact PI
The contribution of the vermiform appendix to Parkinson's disease$446,500
R01 · FY2020 · NS · contact PI
Linking Synucleinopathy and Dysfunction of Olfactory Pathways$557,016
R01 · FY2019 · DC · contact PI
Molecular signatures of Parkinsons disease in the gut and brain$522,500
R21 · FY2019 · NS · contact PI
Combining synucleinopathy and mitochondrial deficits in a novel mouse model of Parkinsons disease$471,170
R21 · FY2019 · NS · contact PI
Promoting survival of dopamine neurons in models of Parkinsons disease using a novel transcriptional regulator$215,725
R21 · FY2019 · NS · contact PI
Linking Synucleinopathy and Dysfunction of Olfactory Pathways$560,738
R01 · FY2018 · DC · contact PI
Promoting survival of dopamine neurons in models of Parkinsons disease using a novel transcriptional regulator$292,250
R21 · FY2018 · NS · contact PI
Linking Synucleinopathy and Dysfunction of Olfactory Pathways$571,807
R01 · FY2017 · DC · contact PI
Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology$237,500
R21 · FY2017 · NS · contact PI
Does Microglial Activation Influence Propagation of Alpha-synuclein Pathology$285,000
R21 · FY2016 · NS · contact PI
Grand Challenges in Parkinson's Disease$10,000
R13 · FY2015 · NS · contact PI
Grand Challenges in Parkinson's Disease$15,000
R13 · FY2014 · NS · contact PI